Quantum Reports Second Quarter Fiscal 2023 Results

Revenue of $99.1 Million at High-End of Guidance Amid Improving Supply Chain; Guides to Continued Revenue Growth

SAN JOSE, Calif., Nov. 2, 2022 /PRNewswire/ -- Quantum Corporation (NASDAQ: QMCO) announced today financial results for its fiscal second quarter ended September 30, 2022.

Second Quarter Fiscal 2023 Financial Summary

  • Revenue increased 6% year-over-year and 2% sequentially to $99.1 million, which was at the high-end of guidance
  • Backlog at quarter end was a record $96.1 million, primarily reflecting future orders by hyperscale customers
  • Active subscription customers grew to over 550, an increase of more than 180% year-over-year and 22% sequentially
  • GAAP net loss was $11.9 million, or ($0.13) per share; adjusted non-GAAP net loss was $0.5 million, or ($0.01) per share
  • Adjusted EBITDA improved to $4.1 million.

"Our supply chain continued to improve in the quarter, underscored by greater availability of materials at more standard pricing and lead times," said Jamie Lerner, Chairman and CEO of Quantum. "These business conditions contributed to revenue being at the high-end of guidance as well as sequential improvements in our overall operating performance for the quarter. Notably, our record backlog consists almost entirely of forward orders from our hyperscale customers and no new unfulfilled orders associated with supply chain constraints. We anticipate these overall favorable trends to extend into the next fiscal quarter, resulting in our expectation for revenue to exceed $100 million."

"Further, our continued execution and cost containment measures lowered our non-GAAP operating expenses to slightly below $35 million, contributing to increased operating leverage as we continue to scale our business."

Second Quarter Fiscal 2023 vs. Prior Quarter

Revenue for the second quarter fiscal 2023 was $99.1 million compared to $97.1 million in the prior quarter. Gross profit in the second quarter of fiscal 2023 was $27.8 million, or 28% of revenue, compared to $34.0 million, or 35% of revenue, in the first quarter of fiscal 2023. Second quarter GAAP gross profit included an extraordinary inventory reserve provision primarily caused by global supply chain disruptions since the start of the pandemic and the longer associated lead times that resulted in older generation products being displaced by next-generation solutions. Non-GAAP gross margin was 35% in the second quarter, which was comparable sequentially.

Total GAAP operating expenses in the second quarter of fiscal 2023 decreased to $39.0 million, or 39% of revenue, compared to $41.1 million, or 42% of revenue, in the prior quarter. Selling, general and administrative expenses were $27.5 million in the quarter, compared to $28.3 million in the prior quarter. Research and development expenses were $10.5 million in the second quarter of fiscal 2023, compared to $12.1 million in the prior quarter. Non-GAAP operating expenses in the second quarter of 2023 decreased to $34.8 million from $36.3 million in the prior quarter.

GAAP net loss in the second quarter of fiscal 2023 was $11.9 million, or ($0.13) per share, compared to a net loss of $10.6 million, or ($0.13) per share, in the first fiscal quarter 2023. Excluding stock compensation, restructuring charges and other non-recurring costs, non-GAAP adjusted loss in the second fiscal quarter of 2023 was $0.5 million, or ($0.01) per share, compared to adjusted net loss of $3.6 million, or ($0.04) per share, in the prior quarter.

Adjusted EBITDA in the second quarter of fiscal 2023 was $4.1 million, compared to $0.3 million in the prior quarter.

Balance Sheet and Liquidity 

  • Cash and cash equivalents including restricted cash was $25.9 million as of September 30, 2022, compared to $26.8 million as of June 30, 2022.
  • Outstanding term loan debt was $77.2 million as of September 30, 2022, compared to $78.4 million as of June 30, 2022. Outstanding borrowings on the Company's revolving credit facility were $21.5 million as of September 30, 2022, compared to $17.3 million as of June 30, 2022.
  • Total interest expense in the second quarter 2023 was $2.7 million compared to $2.1 million in the prior quarter and $3.1 million during the same quarter a year ago.

Outlook

The Company expects the following guidance for the third fiscal quarter of 2023:

  • Revenues of $103 million, plus or minus $3 million
  • Non-GAAP adjusted net loss of ($1.5 million), plus or minus $1 million
  • Non-GAAP adjusted net loss per share of ($0.01), plus or minus $0.01
  • Adjusted EBITDA of approximately $3.5 million

Conference Call and Webcast

Management will host a live conference call today, November 2, 2022, at 5:00 p.m. ET (2:00 p.m. PT) to discuss these results. The conference call will be accessible by dialing 866-424-3436 (U.S. Toll-Free) or +1-201-689-8058 (International) and entering conference ID 13732851. This conference call will be broadcast live over the Internet with a slide presentation and can be accessed by all interested parties on the investor relations section of the Company's website at investors.quantum.com under the events and presentations tab.

A telephone replay of the conference call will be available approximately two hours after the conference call and will be available through November 9, 2022. To access the replay dial 1-877-660-6853 and enter the conference ID 13732851 at the prompt. International callers should dial +1-201-612-7415 and enter the same conference ID. Following the conclusion of the live call, a replay of the webcast will be available on the Company's website for at least 90 days.

About Quantum

Quantum technology, software, and services provide the solutions that today's organizations need to make video and other unstructured data smarter – so their data works for them and not the other way around. With over 40 years of innovation, Quantum's end-to-end platform is uniquely equipped to orchestrate, protect, and enrich data across its lifecycle, providing enhanced intelligence and actionable insights. Leading organizations in cloud services, entertainment, government, research, education, transportation, and enterprise IT trust Quantum to bring their data to life, because data makes life better, safer, and smarter. Quantum is listed on Nasdaq (QMCO). For more information visit www.quantum.com.

Quantum and the Quantum logo are registered trademarks of Quantum Corporation and its affiliates in the United States and/or other countries. All other trademarks are the property of their respective owners.

Forward-Looking Information

The information provided in this press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 ("Exchange Act"). These forward-looking statements are largely based on our current expectations and projections about future events and financial trends affecting our business. Such forward-looking statements include, in particular, statements related to future projections of our financial results;  our expectations to continue our operational execution; our anticipation that overall favorable trends in our business, including in our supply chain, extend into our next fiscal quarter; statements about our backlog and the implication that this backlog will translate into future revenue; the trend in our underlying business remaining robust; and the Company's position for long-term sustainable growth and profitability.

These forward-looking statements may be identified by the use of terms and phrases such as "anticipates", "believes", "can", "could", "estimates", "expects", "forecasts", "intends", "may", "plans", "projects", "targets", "will", and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters and other statements regarding matters that are not historical are forward-looking statements. Investors are cautioned that these forward-looking statements relate to future events or our future performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements.

These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: risks related to the need to address the many challenges facing our business; the potential impact of the COVID-19 pandemic and macroeconomic and inflationary conditions on our business, including potential disruptions to our supply chain, employees, operations, sales and overall market conditions; the competitive pressures we face; risks associated with executing our strategy; the distribution of our products and the delivery of our services effectively; our ability to integrate the business, products, employees and other aspects of our recent acquisitions; the development and transition of new products and services and the enhancement of existing products and services to meet customer needs and respond to emerging technological trends; estimates and assumptions related to the cost (including any possible disruption of our business) and the anticipated benefits of the transformation and restructuring plans; the outcome of any claims and disputes; and other risks that are described herein, including but not limited to the items discussed in "Risk Factors" in our filings with the Securities and Exchange Commission, including our Form 10-K filed with the Securities and Exchange Committee on June 8, 2022. The Company does not intend to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law or regulation.

Investor Relations Contacts:
Shelton Group
Leanne K. Sievers | Brett L. Perry
P: 949-224-3874 | 214-272-0070
E: sheltonir@sheltongroup.com

QUANTUM CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts, unaudited)



September 30, 2022


March 31, 2022

Assets




Current assets:




Cash and cash equivalents

$                            25,698


$                             5,210

Restricted cash

223


283

Accounts receivable, net of allowance for doubtful accounts of $195 and $422

61,309


69,354

Manufacturing inventories

23,671


33,546

Service parts inventories

25,458


24,254

Prepaid expenses

9,241


7,853

Other current assets

4,839


4,697

Total current assets

150,439


145,197

Property and equipment, net

15,973


12,853

Intangible assets, net

7,245


9,584

Goodwill

12,969


12,969

Right-of-use assets, net

10,579


11,107

Other long-term assets

12,477


9,925

Total assets

$                          209,682


$                          201,635

Liabilities and Stockholders' Deficit




Current liabilities:




Accounts payable

$                            34,263


$                           34,220

Deferred revenue

70,184


86,517

Long-term debt, current portion

5,000


4,375

Accrued compensation

13,192


16,141

Other accrued liabilities

14,502


16,562

Total current liabilities

137,141


157,815

Deferred revenue

40,165


41,580

Revolving credit facility

21,500


17,735

Long-term debt, net of current portion

68,250


89,448

Operating lease liabilities

10,315


9,891

Other long-term liabilities

11,653


11,849

Total liabilities

289,024


328,318

Stockholders' deficit




Preferred stock, 20,000 shares authorized; no shares issued and outstanding


Common stock, $0.01 par value; 225,000 shares authorized; 92,158 and 60,433
shares issued and outstanding

922


605

Additional paid-in capital

716,800


645,038

Accumulated deficit

(793,067)


(770,903)

Accumulated other comprehensive loss

(3,997)


(1,423)

Total stockholders' deficit

(79,342)


(126,683)

Total liabilities and stockholders' deficit

$                          209,682


$                          201,635

 

QUANTUM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except per share amounts, unaudited)



Three Months Ended September 30,


Six Months Ended September 30,


2022


2021


2022


2021

Revenue:








   Product

$                62,967


$                54,655


$               123,178


$               106,786

   Service and subscription

32,692


34,359


66,116


67,189

   Royalty

3,478


4,166


6,918


8,303

      Total revenue

99,137


93,180


196,212


182,278

Cost of revenue:








   Product

56,561


41,124


104,482


79,864

   Service and subscription

14,745


13,669


29,850


26,748

      Total cost of revenue

71,306


54,793


134,332


106,612

Gross profit

27,831


38,387


61,880


75,666

Operating expenses:








   Research and development

10,546


12,389


22,671


23,680

   Sales and marketing

15,593


15,462


31,555


29,414

   General and administrative

11,940


11,466


24,254


23,293

   Restructuring charges

921


8


1,646


274

      Total operating expenses

39,000


39,325


80,126


76,661

Loss from operations

(11,169)


(938)


(18,246)


(995)

Other income (expense), net

2,431


126


3,182


(71)

Interest expense

(2,745)


(3,070)


(4,836)


(6,956)

Loss on debt extinguishment


(4,960)


(1,392)


(4,960)

Net loss before income taxes

(11,483)


(8,842)


(21,292)


(12,982)

Income tax provision

461


411


872


424

Net loss

$               (11,944)


$                 (9,253)


$               (22,164)


$               (13,406)

Deemed dividend on warrants



(389)


Net loss attributable to common stockholders

$               (11,944)


$                 (9,253)


$               (22,553)


$               (13,406)









Net loss per share attributable to common stockholders

$                   (0.13)


$                   (0.16)


$                   (0.26)


$                   (0.23)

Weighted average shares - basic and diluted

91,550


58,567


87,617


57,852









Net loss

$               (11,944)


$                 (9,253)


$               (22,164)


$               (13,406)

Foreign currency translation adjustments, net

(1,298)


(506)


(2,574)


(239)

Total comprehensive loss

$               (13,242)


$                 (9,759)


$               (24,738)


$               (13,645)

 

QUANTUM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)



Six Months Ended September 30,


2022


2021

Operating activities




Net loss

$                           (22,164)


$                           (13,406)

  Adjustments to reconcile net loss to net cash used in operating activities  




Depreciation and amortization

5,133


3,967

Amortization of debt issuance costs

768


1,629

Loss on debt extinguishment

992


Provision for product and service inventories

9,946


2,418

Stock-based compensation

5,357


6,273

Paycheck Protection Program loan forgiveness


(10,000)

Non-cash loss on debt extinguishment


8,471

Other

(152)


41

Unrealized foreign exchange loss

(2,766)


(61)

Changes in assets and liabilities:




Accounts receivable, net

8,264


10,024

Manufacturing inventories

416


(5,199)

Service parts inventories

(1,971)


(1,818)

Prepaid expenses

(1,208)


(3,224)

Accounts payable

293


1,559

Accrued restructuring charges

115


(560)

Accrued compensation

(2,949)


(3,779)

Deferred revenue

(17,747)


(9,032)

Other current assets

(486)


(962)

Other non-current assets

(349)


(1,266)

Other current liabilities

769


(353)

Other non-current liabilities

(196)


16

Net cash used in operating activities

(17,935)


(15,262)

Investing activities




Purchases of property and equipment

(7,795)


(2,396)

Business acquisition payments

(2,000)


(5,000)

Net cash used in investing activities

(9,795)


(7,396)

Financing activities




Repayments of long-term debt and payment of amendment fees

(22,096)


(93,051)

Borrowings of credit facility

229,605


126,084

Repayments of credit facility and payment of amendment fees

(226,240)


(116,084)

Proceeds from issuance of common stock, net

66,723


806

Net cash provided by financing activities

47,992


12,716

Effect of exchange rate changes on cash, cash equivalents and restricted cash

166


12

Net change in cash, cash equivalents and restricted cash   

20,428


(9,930)

Cash, cash equivalents, and restricted cash at beginning of period

5,493


33,137

Cash, cash equivalents, and restricted cash at end of period

$                             25,921


$                             23,207

Cash, Cash Equivalents and Restricted Cash at end of period

Cash and cash equivalents

$                            25,698


$                            22,757

Restricted cash, current

223


450

Cash and cash equivalents at the end of period

$                             25,921


$                             23,207

Supplemental disclosure of cash flow information




      Cash paid for interest

$                               4,114


$                               5,198

      Cash paid for income taxes, net

$                                 465


$                                 480

   Non-cash transactions




      Purchases of property and equipment included in accounts payable

$                                  548


$                                  309

     Transfer of manufacturing inventory to services inventory

$                               1,905


$                                    —

     Transfer of manufacturing inventory to property and equipment

$                                  279


$                                    76

     Paid-in-kind interest

$                                  319


$                                    —

     Deemed dividend on warrants

$                                  389


$                                    —

NON-U.S. GAAP FINANCIAL MEASURES

To provide investors with additional information regarding our financial results, we have presented Adjusted EBITDA and Adjusted Net Income (Loss), non-U.S. GAAP financial measures defined below.

Adjusted EBITDA is a non-U.S. GAAP financial measure defined by us as net loss before interest expense, net, provision for income taxes, depreciation and amortization expense, stock-based compensation expense, restructuring charges, and other non-recurring expenses.

"GAAP net loss" as referred to in this press release represents "Net loss attributable to common stockholders". Adjusted Net Income (Loss) is a non-U.S. GAAP financial measure defined by us as net loss before restructuring charges, stock-based compensation expense, and other non-recurring (income) expenses. The Company calculates Adjusted Net Income (Loss) per Basic and Diluted share using the Company's above-referenced definition of Adjusted Net Income (Loss).

We have provided below a reconciliation of Adjusted EBITDA and Adjusted Net Income (Loss) to Net Income (Loss), the most directly comparable U.S. GAAP financial measure. We have presented Adjusted EBITDA because it is a key measure used by our management and the board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short and long-term operating plans. In particular, we believe that the exclusion of the amounts eliminated in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core business performance. For example, in the quarter ended September 30, 2022, we have excluded a large inventory reserve provision caused by global supply chain disruptions since the start of the pandemic and the longer associated lead times that resulted in older generation products being displaced by next-generation solutions. We do not believe an inventory adjustment of this magnitude is reasonably likely to reoccur in the foreseeable future and do not believe it is indicative of our ongoing operations; accordingly, we have excluded its impact from our non-GAAP results. We believe Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Basic and Diluted Share serve as appropriate measures to be used in evaluating the performance of our business and help our investors better compare our operating performance over multiple periods. Accordingly, we believe that Adjusted EBITDA and Adjusted Net Income (Loss) provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and our board of directors.

Our use of Adjusted EBITDA and Adjusted Net Income (Loss) have limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our financial results as reported under U.S. GAAP. Some of these limitations are as follows:

  • Although depreciation and amortization expense are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
  • Adjusted EBITDA does not reflect: (1) interest and tax payments that may represent a reduction in cash available to us; (2) capital expenditures, future requirements for capital expenditures or contractual commitments; (3) changes in, or cash requirements for, working capital needs; (4) the potentially dilutive impact of stock-based compensation expense; (5) potential future costs related to our long-term debt; (6) potential future restructuring expenses; (7) potential future costs related to business acquisitions; (8) gain (loss) on debt extinguishment, (9) and acquisition-related amortization of intangibles assets from business combinations, (10) deemed dividend related to warrants, or (11) manufacturing inventory provisions.
  • Adjusted Net Income (Loss) does not reflect: (1) potential future restructuring activities; (2) the potentially dilutive impact of stock-based compensation expense; (3) potential future costs related to our long-term debt; (4) potential future costs related to business acquisitions; (5) gain (loss) on debt extinguishment,  (6) acquisition-related amortization of intangibles assets from business combinations, (7) deemed dividend related to warrants, or (8) manufacturing inventory provisions.

Other companies, including companies in our industry, may calculate Adjusted EBITDA, Adjusted Net Income (Loss) or similarly titled measures differently, which reduces its usefulness as a comparative measure.

Because of these and other limitations, you should consider Adjusted EBITDA and Adjusted Net Income (Loss) along with other U.S. GAAP-based financial performance measures, including various cash flow metrics and our U.S. GAAP financial results.

The following is a reconciliation of Adjusted EBITDA to the most comparable U.S. GAAP financial measure, Net Income (Loss) (dollars in thousands):


Three Months Ended September 30,


Six Months Ended September 30,


2022


2021


2022


2021

Net loss attributable to common stockholders

$               (11,944)


$                 (9,253)


$               (22,553)


$               (13,406)

Interest expense, net

2,745


3,070


4,836


6,956

Provision for income taxes

461


411


871


424

Depreciation expense

1,372


1,688


2,794


3,031

Stock-based compensation expense

2,288


3,072


5,357


6,273

Restructuring charges

921


8


1,646


274

Loss on extinguishment of Senior Secured Term Loan


14,960


1,392


14,960

Gain on PPP loan forgiveness


(10,000)



(10,000)

Amortization of acquisition related intangible assets

1,175


471


2,339


936

Acquisition-related costs

65


811


192


950

Long-term debt related costs

108


45


274


252

Deemed dividend related to warrants



389


Manufacturing inventory provision

6,926



6,926


Adjusted EBITDA

$                  4,117


$                  5,283


$                  4,463


$                10,650









The following is a reconciliation of Adjusted Net Income to the most comparable U.S. GAAP financial measure,
Net Income (Loss) (in thousands):


Three Months Ended September 30,


Six Months Ended September 30,


2022


2021


2022


2021

Net loss attributable to common stockholders

$               (11,944)


$                 (9,253)


$               (22,553)


$               (13,406)

Stock-based compensation

2,288


3,072


5,357


6,273

Restructuring charges

921


8


1,646


274

Loss on extinguishment of Senior Secured Term Loan


14,960


1,392


14,960

Gain on PPP loan forgiveness


(10,000)



(10,000)

Amortization of acquisition related intangible assets

1,175


471


2,339


936

Acquisition-related costs

65


811


192


950

Long-term debt related costs

108


45


274


252

Deemed dividend related to warrants



389


Manufacturing inventory provision

6,926



6,926


   Adjusted net income (loss)

$                    (461)


$                     114


$                 (4,038)


$                     239









   Adjusted Net Income (Loss) per share:








      Basic

$                   (0.01)


$                    0.00


$                   (0.05)


$                    0.00

      Diluted

$                   (0.01)


$                    0.00


$                   (0.05)


$                    0.00

   Weighted average shares outstanding:








      Basic

91,550


50,129


87,617


57,852

      Diluted

91,550


68,565


87,617


68,167

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quantum-reports-second-quarter-fiscal-2023-results-301666775.html

SOURCE Quantum Corp.